Results 41 to 50 of about 8,668 (131)

Onset of valganciclovir resistance in two infants with congenital cytomegalovirus infection

International Journal of Infectious Diseases, 2020
Ganciclovir and its prodrug valganciclovir are elective treatments for cCMV. Neonates with important symptoms undergo 6 months of therapy to ameliorate/prevent symptoms and late sequelae, but evidence of resistance is emerging.
Francesca Garofoli, Giuseppina Lombardi, Micol Angelini, Giulia Campanini, Maurizio Zavattoni, Fausto Baldanti   +5 more
doaj   +1 more source

Cytomegalovirus Infection in Kidney Transplant Recipients

Southeastern European Medical Journal, 2021
Introduction: Present study examined the frequency of CMV infection during follow-up using quantitative nucleic acid amplification testing, the frequency of administration of infection prophylaxis, viremia and infection in kidney transplant recipients ...
Dino Šisl, Lada Zibar
doaj   +1 more source

CMV Preventive and Treatment Studies in Children Undergoing Haematopoietic Stem Cell Transplant: A Systematic Review

Reviews in Medical Virology, Volume 36, Issue 2, March 2026.
ABSTRACT Cytomegalovirus (CMV) is one of the most important infectious causes of morbidity and mortality in children undergoing haematopoietic stem cell transplant (HSCT). However, the evidence for preventing and treating CMV disease in children in this context remains limited. We sought to review the current available evidence regarding the prevention
Lara Fusani, Eleonora Fusco, Mariana Fonseca, Judith Breuer, Kanchan Rao, Luisa Galli, Alasdair Bamford, Seilesh Kadambari   +7 more
wiley   +1 more source

Adverse event profile differences between maribavir and valganciclovir: findings from the FDA adverse event reporting system

Frontiers in Pharmacology
BackgroundMaribavir and valganciclovir are pharmacotherapeutic options utilized in the management of cytomegalovirus (CMV) infection post-transplantation.
Haolin Teng, Shengnan Zhang, Jinyu Yu, Faping Li   +3 more
doaj   +1 more source

Alemtuzumab Induction in Septuagenarians Undergoing Deceased Donor Kidney Transplantation

Clinical Transplantation, Volume 40, Issue 3, March 2026.
ABSTRACT Introduction The anti‐CD52 monoclonal antibody alemtuzumab is used as an induction agent in kidney transplantation (KT) but remains understudied in septuagenarian recipients. The study purpose was to analyze the safety and efficacy of single‐dose alemtuzumab induction in septuagenarian deceased donor (DD) KT recipients.
David I. Harriman, Alex Ng, Alan C. Farney, Giuseppe Orlando, Colleen Jay, Amber Reeves‐Daniel, Robert J. Stratta   +6 more
wiley   +1 more source

Efficacy of Low Dose Valganciclovir Prophylaxis for Cytomegalovirus Infection in Kidney Transplantation

Haseki Tıp Bülteni, 2020
Aim:Valganciclovir is the preferred drug for chemoprophylaxis for the prevention of cytomegalovirus (CMV) infection in kidney recipients. Low-dose (450 mg/day) valganciclovir use is gaining popularity because standard dose (900 mg/day) has negative ...
Ümit Özçelik, Nadir Alpay, Eryiğit Eren, Bora Uslu, Ahmet Cem Yardımcı   +4 more
doaj   +1 more source

Characterising Hand Tremor in Adult Kidney Transplant Recipients: Its Impact on Daily Activities and Relationship With Tacrolimus Administration and Exposure

Nephrology, Volume 31, Issue 3, March 2026.
ABSTRACT Aim This study aimed to characterise hand tremor and examine its relationship with tacrolimus administration time and systemic exposure in adult kidney transplant recipients early post‐transplantation. Methods Quantitative and qualitative data on hand tremor were collected from patients receiving immediate‐release tacrolimus, approximately 1 ...
Catherine P. King, Amelia R. Cossart, Nicole M. Isbel, Scott B. Campbell, Meng‐Wong Taing, Diana R. Leary, Vincent T. Houlihan, Christine E. Staatz   +7 more
wiley   +1 more source

Ruxolitinib and vedolizumab salvage therapy in the setting of cytomegalovirus colitis for a patient with newly diagnosed very early onset inflammatory bowel disease

JPGN Reports, Volume 7, Issue 1, Page 114-117, February 2026.
Abstract Acute severe ulcerative colitis increases the risk for cytomegalovirus (CMV) infection, particularly with the use of immunocompromising medications. We report a case of a 4‐year‐old with newly diagnosed very early onset inflammatory bowel disease presenting with acute severe colitis refractory to both corticosteroids and infliximab, whose ...
Alison Laxer, Morris Edelman, Julie Gallagher, Benjamin Sahn   +3 more
wiley   +1 more source

Interferon‐gamma blocking as a promising treatment for severe liver dysfunction in secondary hemophagocytic lymphohistiocytosis after liver transplantation

JPGN Reports, Volume 7, Issue 1, Page 14-18, February 2026.
Abstract Hemophagocytic lymphohistiocytosis (HLH) is a life‐threatening hyperinflammatory syndrome that can occur after solid organ transplantation but remains underrecognized in this setting. The diagnosis is often delayed due to overlapping clinical manifestations with infection, rejection, or malignancy, and management becomes particularly ...
Chen Chen, Tao Zhou, Jing Jin, Yi Luo, Lijing Shen, Qiang Xia, Yongbing Qian   +6 more
wiley   +1 more source

Cytomegalovirus retinitis treated with valganciclovir in Wegener’s granulomatosis

Clinical Ophthalmology, 2012
Yoshiaki Kabata1, Genichiro Takahashi1, Hiroshi Tsuneoka21Department of Ophthalmology, Jikei University School of Medicine, Katsushika Medical Center, Katsushika, Tokyo, Japan; 2Department of Ophthalmology, Jikei University School of Medicine, Minato ...
Kabata Y, Takahashi G, Tsuneoka H
doaj